AAAAAA
Results:
1-12
|
Results: 12
Authors:
RIVERA E
CHEVLEN E
ECKARDT J
KENNEDY MJ
SAWHNEY R
SUTTON L
FRYE D
HEDRICK J
MCGUIRT C
LEVIN J
HOHNEKER J
WHITE R
HORTOBAGYI GN
Citation: E. Rivera et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY ORAL REGIMEN OF 5-FLUOROURACIL (5-FU) PLUS ENILURACIL FOR THE TREATMENT OF PATIENTS WITH TAXANE AND ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 70-70
Authors:
LOKICH J
BECK T
CHEVLEN E
HOCHSTER H
OROURKE M
WEAVER C
BELL W
MCGUIRT C
LEVIN J
HOHNEKER J
MANI S
Citation: J. Lokich et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 169-169
Authors:
SCHILSKY RL
HOHNEKER J
RATAIN MJ
JANISCH L
SMETZER L
LUCAS VS
KHOR SP
DIASIO R
VONHOFF DD
BURRIS HA
Citation: Rl. Schilsky et al., PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF ENILURACIL PLUS FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1450-1457
Authors:
PEACOCK NW
BURRIS HA
DIERAS V
SMITH L
RODRIGUEZ GI
ECKARDT JR
JONES SF
HARDY J
HOHNEKER J
BIGLEY J
VONHOFF DD
Citation: Nw. Peacock et al., A PHASE-I TRIAL OF VINORELBINE IN COMBINATION WITH MITOXANTRONE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Investigational new drugs, 16(1), 1998, pp. 37-43
Authors:
GERSHENSON DM
BURKE TW
MORRIS M
BAST RC
GUASPARI A
HOHNEKER J
WHARTON JT
Citation: Dm. Gershenson et al., A PHASE-I STUDY OF A DAILY X3 SCHEDULE OF INTRAVENOUS VINORELBINE FORREFRACTORY EPITHELIAL OVARIAN-CANCER, Gynecologic oncology (Print), 70(3), 1998, pp. 404-409
Authors:
NEW P
VOKES E
ROGERS L
BAZAN C
HOHNEKER J
EBLE M
VILK P
Citation: P. New et al., LONG-TERM RESPONSE TO CRISNATOL MESYLATE IN PATIENTS WITH GLIOMA, Investigational new drugs, 15(4), 1997, pp. 343-352
Authors:
CRAWFORD J
OROURKE M
SCHILLER JH
SPIRIDONITIS CH
YANOVICH S
OZER H
LANGLEBEN A
HUTCHINS L
KOLETSKY A
CLAMON G
BURMAN S
WHITE R
HOHNEKER J
Citation: J. Crawford et al., RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2774-2784
Authors:
WEBER BL
VOGEL C
JONES S
HARVEY H
HUTCHINS L
BIGLEY J
HOHNEKER J
Citation: Bl. Weber et al., INTRAVENOUS VINORELBINE AS FIRST-LINE AND 2ND-LINE THERAPY IN ADVANCED BREAST-CANCER, Journal of clinical oncology, 13(11), 1995, pp. 2722-2730
Authors:
JONES S
WINER E
VOGEL C
LAUFMAN L
HUTCHINS L
OROURKE M
LEMBERSKY B
BUDMAN D
BIGLEY J
HOHNEKER J
Citation: S. Jones et al., RANDOMIZED COMPARISON OF VINORELBINE AND MELPHALAN IN ANTHRACYCLINE-REFRACTORY ADVANCED BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2567-2574
Authors:
MOINPOUR CM
DONALDSON G
MCSORLEY P
BERTSCH L
HOHNEKER J
Citation: Cm. Moinpour et al., PSYCHOMETRIC PROPERTIES OF QUALITY-OF-LIFE MEASURES USED WITH STAGE-IV NONSMALL CELL LUNG-CANCER PATIENTS, Quality of life research, 3(1), 1994, pp. 86-87
Authors:
VOKES EE
ROSENBERG R
JAHANZEB M
CRAIG J
GRALLA R
BELANI C
JONES S
BIGLEY J
HOHNEKER J
OROURKE MA
CRAWFORD J",VOGEL,TUTTLE,"VIALLET J
BURRIS HA
COLTMAN CA
MOINPOUR CM
Citation: Ee. Vokes et al., ORAL VINORELBINE (NAVELBINE) IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT, Seminars in oncology, 21(5), 1994, pp. 35-41
Authors:
VIALLET J
AYOUB J
ROUSSEAU P
SOUHAMI L
HOHNEKER J
SHEPHERD F
Citation: J. Viallet et al., VINORELBINE (NAVELBINE) IN THE ADJUVANT AND NEOADJUVANT TREATMENT OF NONSMALL CELL LUNG-CANCER, Seminars in oncology, 21(5), 1994, pp. 64-72
Risultati:
1-12
|